Skip to main content
SpringerLink
Log in

Arrhythmias During Pregnancy

Special Considerations

  • Chapter
Management of Cardiac Arrhythmias

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 114 Accesses

Abstract

Cardiac arrhythmias that occur during pregnancy represent a unique problem, since two lives may be in jeopardy. Most arrhythmias originate in the mother, but occasionally fetal arrhythmias require therapy through maternal administration of drugs. When considering therapeutic interventions, pro-arrhythmia and other adverse effects to both the mother and fetus must be considered. There are also unique risks to the fetus, such as congenital malformations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 1993; 36: 137–178.

    Article  PubMed  CAS  Google Scholar 

  2. Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis 1974; 16: 363–374.

    Article  PubMed  CAS  Google Scholar 

  3. Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. Br J Obstet Gynaecol 1981; 88: 1–9.

    Article  PubMed  CAS  Google Scholar 

  4. Mitani R, Steinberg I, Lien E, Harrison E, Elkayam U. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet 1987; 12: 253–291.

    Article  PubMed  CAS  Google Scholar 

  5. Widerhorn J, Widerhorn AL, Rahimtoola SH, Elkayam U. WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J 1992; 123: 796–798.

    Article  PubMed  CAS  Google Scholar 

  6. Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 1997; 79: 1061–1064.

    Article  PubMed  CAS  Google Scholar 

  7. Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M. New-onset ventricular tachycardia during pregnancy. Am Heart J 1992; 123: 933–941.

    Article  PubMed  CAS  Google Scholar 

  8. Perloff J. Pregnancy and congenital heart disease. J Am Coll Cardiol 1991; 18: 340–342.

    Article  PubMed  CAS  Google Scholar 

  9. Lee W, Cotton D. Peripartum cardiomyopathy: current concepts and clinical management. Clin Obstet Gynecol 1989; 32: 54–67.

    Article  PubMed  CAS  Google Scholar 

  10. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984; 24: 129–147.

    Article  PubMed  CAS  Google Scholar 

  11. Meyer J, Lackner J, Schochet S. Paroxysmal tachycardia in pregnancy. Am HeartJ 1931; 94: 1901–1904.

    Google Scholar 

  12. Hill L, Malkasian G. The use of quinidine sulfate throughout pregnancy. Obstet Gynecol 1979;54:366– 368.

    Google Scholar 

  13. Wladimiroff J, Stewart A. Treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985; 34: 134–140.

    PubMed  CAS  Google Scholar 

  14. Wong R, Murthy A, Mathisen G, Glover N, Thornton P. Treatment of severe falciparum malaria during pregnancy with quinidine and exchange transfusions. Am J Med 1992; 92: 561–562.

    Article  PubMed  CAS  Google Scholar 

  15. Rotmensh H, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 1983; 98: 487–497.

    Article  Google Scholar 

  16. Allen NM, Page RL. Procainamide administration during pregnancy. Clin Pharmacol 1993; 12: 58–60.

    CAS  Google Scholar 

  17. Page RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995; 130: 871–876.

    Article  PubMed  CAS  Google Scholar 

  18. Schnider S. Choice of anesthesia for labor and delivery. Obstet Gynecol 1981; 58: 24s–34s.

    Google Scholar 

  19. Martin L, Jurand A. The absence of teratogenic effects of some analgesics use in anesthesia: additional evidence from a mouse model. Anaesthesia 1992; 47: 473–476.

    Article  PubMed  CAS  Google Scholar 

  20. Kim W, Pomerance J. Miller A. Lidocaine intoxication in a newborn following local anesthesia for episiotomy. Pediatrics 1979; 64: 643–645.

    PubMed  CAS  Google Scholar 

  21. Brown W, Bell G, Alper M. Acidosis, local anesthesia and the newborn. Obstet Gynecol 1976; 48: 27–30.

    PubMed  Google Scholar 

  22. Gregg A, Tomich P. Mexiletine use in pregnancy. J Perinatol 1988; 8: 33–35.

    PubMed  CAS  Google Scholar 

  23. Timmis A, Jackson G, Holt D. Mexiletine for control of ventricular dysrrhythmias during pregnancy. Lancet 1980; 2: 647–648.

    Article  PubMed  CAS  Google Scholar 

  24. Lowes H, Ives T. Mexiletine use in pregnancy and lactation. Am J Obstet Gynecol 1987; 157: 446–447.

    Google Scholar 

  25. Atkinson AJ, Davison R. Diphenylhydantoin as an antiarrhythmic drug. Ann Rev Med 1974; 25: 99–113.

    Article  PubMed  CAS  Google Scholar 

  26. Hanson J, Myrianthopoulos N, Sedwick M, Smith D. Risk to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976; 89: 662–668.

    Article  PubMed  CAS  Google Scholar 

  27. Echt D, Liebson P, Mitchel B, Peters R, Obias-Manno D, Barker A, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991; 324: 781–788.

    Article  PubMed  CAS  Google Scholar 

  28. Wagner X, Jouglard J, Moulin M, Miller AM, Petitjean J, Pisapia A. Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 1990; 119: 700–702.

    Article  PubMed  CAS  Google Scholar 

  29. Ahmed K, Issawi I, Peddireddy R. Use of flecainide for refractory atrial tachycardia of pregnancy. Am J Crit Care 1996; 5: 306–308.

    PubMed  CAS  Google Scholar 

  30. Allan L, Chita S, Sharland G, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991; 65: 46–48.

    Article  PubMed  CAS  Google Scholar 

  31. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenatal Diagn 1995; 15: 1297–1302.

    Article  CAS  Google Scholar 

  32. Simpson J, Sharland G. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998; 79: 576–581.

    PubMed  CAS  Google Scholar 

  33. Vanderhal A, Cocjin J, Santulli T, Carlson D, Rosenthal P. Conjugated hyperbilirubinemia in a newborn infant after maternal (transplacental) treatment with flecainide acetate for fetal tachycardia and fetal hydrops. J Pediatr 1995; 126: 988–990.

    Article  PubMed  CAS  Google Scholar 

  34. Capucci A, Boriani G. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. Drug Saf 1995; 12: 55–72.

    Article  PubMed  CAS  Google Scholar 

  35. Frishman W, Chesner M. Beta-adrenergic blockers in pregnancy. Am Heart J 1988; 115: 147–152.

    Article  PubMed  CAS  Google Scholar 

  36. Joglar JA, Page RL. Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 1999; 20: 85–94.

    Article  PubMed  CAS  Google Scholar 

  37. Pryun S, Phelan J, Buchanan G. Long-term propanolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol 1979; 135: 485–489.

    Google Scholar 

  38. Rubin P, Butters L, Clark D. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983; 2: 431–434.

    Google Scholar 

  39. Wichman K, Ryulden G, Karberg B. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Investig 1984; 169: 90–94.

    Article  CAS  Google Scholar 

  40. Lip G, Beevers M, Churchill D, Shaffer L, Beevers D. Effect of atenolol on birth weight. Am J Cardiol 1997; 79: 1436–1438.

    Article  PubMed  CAS  Google Scholar 

  41. Liedholm H, Melander A, Bitzen P-O, Lonnerholm G, Mattiasson I, Nilsson B, et al. Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol 1981; 20: 229–231.

    Article  PubMed  CAS  Google Scholar 

  42. Delvin R, Duchin K, Fleiss P. Nadolol in human serum and breast milk. Br J Clin Pharmacol 1981; 12: 393–396.

    Article  Google Scholar 

  43. Schmimmel M, Eldelman A, Wilschanski M, Shaw D, Oglivie R, Koren G. Toxic effects of atenolol consumed during breast feeding. J Pediatr 1989; 114: 476–478.

    Article  PubMed  Google Scholar 

  44. Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 1991; 122: 1162–1166.

    Article  PubMed  CAS  Google Scholar 

  45. Wolf DD, Shepper JD, Verhaaren H, Deneyer M, Smitz J, Sacre-Smits L. Congenital hypothyroid goiter and amiodarone. Acta Paediatr Scand 1988; 77: 616–618.

    Article  PubMed  Google Scholar 

  46. Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995; 172: 1307–1311.

    Article  PubMed  CAS  Google Scholar 

  47. Ovadia M, Brito M, Hoyer G, Marcus F. Human experience with amiodarone in the embrionic period. Am J Cardiol 1994; 73: 316–317.

    Article  PubMed  CAS  Google Scholar 

  48. Strunge P, Frandsen J, Andreasen F. Amiodarone during pregnancy. Eur Heart J 1988; 9: 106–109.

    PubMed  CAS  Google Scholar 

  49. O’Hare M, Murnaghan G, Russell C, Leahey W, Varma M. Sotalol as hypotensive agent in pregnancy. Br J Obstet Gynaecol 1980; 87: 814–820.

    Article  PubMed  Google Scholar 

  50. Kowey P, VanderLugt J, Luderer J. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol 1996; 78: 46–52.

    Article  PubMed  CAS  Google Scholar 

  51. Klein V, Repke J. Supraventricular tachycardia in pregnancy: cardioversion with verapamil. Obstet Gynecol 1984; 63: 16S–18S.

    PubMed  CAS  Google Scholar 

  52. Byerly WG, Hartmann A, Foster DE, Tannenbaum AK. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med 1991; 20: 552–554.

    Article  PubMed  CAS  Google Scholar 

  53. Orlandi C, Marlettini M, Cassani A, Trabatti M, Agostini D, Salomone T, et al. Treatment of hypertension during pregnancy with the calcium channel antagonist verapamil. Curr Ther Res 1986; 39: 884–893.

    Google Scholar 

  54. Kleinman C, Copel J, Weinstein E, Santulli T, Hobbins J. Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound 1985; 13: 265–273.

    Article  PubMed  CAS  Google Scholar 

  55. Camm A, Garrat C. Adenosine and supraventricular tachycardia. N Engl J Med 1991; 325: 1621–1629.

    Article  PubMed  CAS  Google Scholar 

  56. Elkayam U, Goodwin TM. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 1995; 75: 521–523.

    Article  PubMed  CAS  Google Scholar 

  57. Jaqueti J, Martinez-Hernandez D, Hernandez-Garcia R, Navarro-Gallar F. Adenosine deaminase in pregnancy serum. Clin Chem 1990; 36: 2144.

    Google Scholar 

  58. Mason B, Ogjunyemi D, Punla O, Koos B. Maternal and fetal cardiorespiratory responses to adenosine in sheep. Am J Obstet Gynecol 1993; 168: 1558–1561.

    Article  PubMed  CAS  Google Scholar 

  59. Page R. Arrhythmias during pregnancy. Cardiac Electrophysiology Review 1997; I278–I282.

    Google Scholar 

  60. Chen V, Tse T, Wong V. Transfer of digoxin across the placenta and into breast milk. Br J Obstet Gynaecol 1978; 55: 605–609.

    Google Scholar 

  61. Rogers M, Willerson J, Goldblatt A, Smith T. Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med 1972; 287: 1010–1013.

    Article  PubMed  CAS  Google Scholar 

  62. Kerenyi T, Gleicher N, Meller J, Brown E, Stenfeld L, Chitkara U, et al. Transplacental cardioversion of intrauterine supraventricular tachycardia with digitalis. Lancet 1980; 2: 393–395.

    Article  PubMed  CAS  Google Scholar 

  63. King C, Mattioli L, Goertz K, Snodgrass W. Successful treatment of fetal supraventricular tachycardia with maternal digoxin therapy. Chest 1984; 85: 573–575.

    Article  PubMed  CAS  Google Scholar 

  64. Parilla BV, Strasburger JF, Socol ML. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am J Perinatol 1996; 13: 483–486.

    Article  PubMed  CAS  Google Scholar 

  65. Gonzalez A, Phelps S, Cochran E, Sibai B. Digitalis-like immunoreactive substance in pregnancy. Am J Obstet Gynecol 1987; 157: 660–664.

    PubMed  CAS  Google Scholar 

  66. Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137– 150.

    Google Scholar 

  67. McAnulty J, Morton M, Ueland K. The heart and pregnancy. Curr Probl Cardiol 1988; 13: 589–665.

    Article  PubMed  CAS  Google Scholar 

  68. Dalvi BV, Chaudhuri A, Kulkarni HL, Kale PA. Therapeutic guidelines for congenital complete heart block presenting in pregnancy. Obstet Gynecol 1992; 79: 802–804.

    PubMed  CAS  Google Scholar 

  69. Antonelli D, Bloch L, Rosenfeld T. Implantation of a permanent dual chamber pacemaker in a pregnant woman by transesophageal echocardiographic guidance. PACE 1999; 22: 534–535.

    Article  PubMed  CAS  Google Scholar 

  70. Guldal M, Kervancioglu C, Oral D, Gurel T, Erol C, Sorrel A. Permanent pacemaker implantation in a pregnant woman with the guidance of ECG and two-dimensional echocardiography. PACE 1987; 10: 543–545.

    Article  Google Scholar 

  71. Jordaens LJ, Vandenbogaerde JF, Van de Bruaene P, Du Buyzere M. Transesophageal echocardiography for insertion of a physiological pacemaker in early pregnancy. PACE 1990; 13: 955–957.

    Article  PubMed  CAS  Google Scholar 

  72. Metcalfe J, McAnulty J, Ueland K. Burwell and Metcalfe’s Heart Disease and Pregnancy: Physiology and Management. Little, Brown and Co., Boston, MA, 1986, p. 58.

    Google Scholar 

  73. Mechem CC, Knopp RK, Feldman D. Painless abruptio placentae associated with disseminated intra-vascular coagulation and syncope. Ann Emerg Med 1992; 21: 883–885.

    Article  PubMed  CAS  Google Scholar 

  74. Kniseley RM. Acute internal bleeding as a cause of syncope. American Family Physician 1995; 52: 1278.

    PubMed  CAS  Google Scholar 

  75. Peleg D, Orvieto R, Ferber A, Ben-Rafael Z. Maternal supraventricular tachycardia recorded as apparent fetal heart rate in a case of fetal demise. Acta Obstet Gynecol Scand 1998; 77: 786–787.

    PubMed  CAS  Google Scholar 

  76. Dominguez A, Iturralde P, Hermosillo AG, Colin L, Kershenovich S, Garrido LM. Successful radiofrequency ablation in an accessory pathway during pregnancy. PACE 1999; 22: 131–134.

    Article  PubMed  CAS  Google Scholar 

  77. Ueland K. Rheumatic heart disease and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac Problems in Pregnancy. Alan R. Liss, New York, NY, 1990, pp. 99–107.

    Google Scholar 

  78. Szekely P, Snaith L. Atrial fibrillation and pregnancy. Br Med J 1961; 1: 1407–1410.

    Article  PubMed  CAS  Google Scholar 

  79. Mendelson C. Disorders of the heart beat during pregnancy. Am J Obstet Gynecol 1956; 72: 1268–1301.

    PubMed  CAS  Google Scholar 

  80. Hall J, Paul R, Wilson K. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122–140.

    Article  PubMed  CAS  Google Scholar 

  81. Dahlman T, Lindvall N, Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: a radiological study post-partum. Br J Obstet Gynaecol 1990; 97: 221–228.

    Article  PubMed  CAS  Google Scholar 

  82. Ginsberg J, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1998; 114: 524s–530s.

    Article  PubMed  CAS  Google Scholar 

  83. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176: 1062–1068.

    Article  PubMed  CAS  Google Scholar 

  84. Dizzon-Townson D, Branch D. Anticoagulation treatment during pregnancy: an update. Semin Thromb Hemost 1998; 24: 55–63.

    Google Scholar 

  85. Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation 1998; 97: 451–456.

    Article  PubMed  CAS  Google Scholar 

  86. Rosemond R. Cardioversion during pregnancy. JAMA 1993; 269: 3167.

    Article  PubMed  CAS  Google Scholar 

  87. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation 1997; 96: 2808–2812.

    Article  PubMed  CAS  Google Scholar 

  88. Kloeck W, Cummins RO, Chamberlain D, Bossaert L, Callanan V, Carli P, et al. Special resuscitation situations: an advisory statement from the International Liaison Committee on Resuscitation. Circulation 1997; 95: 2196–2210.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. José A. Joglar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard L. Page MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Leonard I. Ganz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Joglar, J.A., Page, R.L. (2002). Arrhythmias During Pregnancy. In: Ganz, L.I. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-090-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-090-2_21

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-218-6

  • Online ISBN: 978-1-59259-090-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation